Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-25

FDA Approved: RAMELTEON — Original Application (Xiromed, LLC)

View source ↗

Summary

FDA approved Xiromed, LLC's ramelteon under an Original Application, providing a generic option for adults with insomnia characterized by difficulty with sleep …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ramelteon (ramelteon)

Snippet

ORIG AP for RAMELTEON (RAMELTEON)